|
This quarter we had almost as many deletes as ADDS so I included them which I do not usually do. Please also check out the descriptor changes included herein. For more details on the Quarterly update, click right here. Add means new codes; discontinued means deleted 4/1/2024, and changed means, well, you know.
HCPC ACTION CD LONG DESCRIPTION
G0138 ADD Intravenous infusion of cipaglucosidase alfa-atga, including provider/supplier acquisition and clinical supervision of oral administration of miglustat in preparation of receipt of cipaglucosidase alfa-atga
J0177 ADD Injection, aflibercept hd, 1 mg
J0209 ADD Injection, sodium thiosulfate (hope), 100 mg
J0577 ADD Injection, buprenorphine extended-release (brixadi), less than or equal to 7 days of therapy
J0578 ADD Injection, buprenorphine extended-release (brixadi), greater than 7 days and up to 28 days of therapy
J0589 ADD Injection, daxibotulinumtoxina-lanm, 1 unit
J0650 ADD Injection, levothyroxine sodium, not otherwise specified, 10 mcg
J0651 ADD Injection, levothyroxine sodium (fresenius kabi) not therapeutically equivalent to j0650, 10 mcg
J0652 ADD Injection, levothyroxine sodium (hikma) not therapeutically equivalent to j0650, 10 mcg
J1010 ADD Injection, methylprednisolone acetate, 1 mg
J1202 ADD Miglustat, oral, 65 mg
J1203 ADD Injection, cipaglucosidase alfa-atga, 5 mg
J1323 ADD Injection, elranatamab-bcmm, 1 mg
J1434 ADD Injection, fosaprepitant (focinvez), 1 mg
J2277 ADD Injection, motixafortide, 0.25 mg
J2782 ADD Injection, avacincaptad pegol, 0.1 mg
J2801 ADD Injection, risperidone (rykindo), 0.5 mg
J2919 ADD Injection, methylprednisolone sodium succinate, 5 mg
J3055 ADD Injection, talquetamab-tgvs, 0.25 mg
J3424 ADD Injection, hydroxocobalamin, intravenous, 25 mg
J7165 ADD Injection, prothrombin complex concentrate, human-lans, per i.u. of factor ix activity
J7354 ADD Cantharidin for topical administration, 0.7%, single unit dose applicator (3.2 mg)
J9073 ADD Injection, cyclophosphamide (ingenus), 5 mg
J9074 ADD Injection, cyclophosphamide (sandoz), 5 mg
J9075 ADD Injection, cyclophosphamide, not otherwise specified, 5 mg
J9248 ADD Injection, melphalan (hepzato), 1 mg
J9249 ADD Injection, melphalan (apotex), 1 mg
J9376 ADD Injection, pozelimab-bbfg, 1 mg
Q5133 ADD Injection, tocilizumab-bavi (tofidence), biosimilar, 1 mg
Q5134 ADD Injection, natalizumab-sztn (tyruko), biosimilar, 1 mg
C9159 Discontinued Injection, prothrombin complex concentrate (human), balfaxar, per i.u. of factor ix activity
C9160 Discontinued Injection, daxibotulinumtoxina-lanm, 1 unit
C9161 Discontinued Injection, aflibercept hd, 1 mg
C9162 Discontinued Injection, avacincaptad pegol, 0.1 mg
C9163 Discontinued Injection, talquetamab-tgvs, 0.25 mg
C9164 Discontinued Cantharidin for topical administration, 0.7%, single unit dose applicator (3.2 mg)
C9165 Discontinued Injection, elranatamab-bcmm, 1 mg
J0576 Discontinued Injection, buprenorphine extended-release (brixadi), 1 mg
J1020 Discontinued Injection, methylprednisolone acetate, 20 mg
J1030 Discontinued Injection, methylprednisolone acetate, 40 mg
J1040 Discontinued Injection, methylprednisolone acetate, 80 mg
J1840 Discontinued Injection, kanamycin sulfate, up to 500 mg
J1850 Discontinued Injection, kanamycin sulfate, up to 75 mg
J2920 Discontinued Injection, methylprednisolone sodium succinate, up to 40 mg
J2930 Discontinued Injection, methylprednisolone sodium succinate, up to 125 mg
J9070 Discontinued Cyclophosphamide, 100 mg
J9250 Discontinued Methotrexate sodium, 5 mg
Q4244 Discontinued Procenta, per 200 mg
J0208 Description Chg Injection, sodium thiosulfate (pedmark), 100 mg
J0612 Description Chg Injection, calcium gluconate, not otherwise specified, 10 mg
J0613 Description Chg Injection, calcium gluconate (wg critical care), not therapeutically equivalent to j0612, 10 mg
J3380 Description Chg Injection, vedolizumab, intravenous, 1 mg
J3425 Description Chg Injection, hydroxocobalamin, intramuscular, 10 mcg
J7516 Description Chg Injection, cyclosporine, 250 mg
J9029 Description Chg Intravesical instillation, nadofaragene firadenovec-vncg, per therapeutic dose
J9260 Description Chg Injection, methotrexate sodium, 50 mg
Also, there was a note for J9071 Cyclophosphamide 5 mg (Auromedics) and J9072 Cyclophosphamide 5 mg (Dr. Reddy's) that they have coverage and long descriptor change. I cannot see what the description change is and it is not obvious what the coverage change is. Check with your MAC's web site around April 1.
|